| Literature DB >> 21702979 |
Dejan Z Orčić1, Neda M Mimica-Dukić, Marina M Francišković, Slobodan S Petrović, Emilija D Jovin.
Abstract
BACKGROUND: The St John's Wort (Hypericum perforatum; Clusiaceae) has been used in traditional and modern medicine for a long time due to its high content of biologically active phenolics. The purpose of this work was to develop a method for their fractionation and identification, and to determine the most active antioxidant compounds in plant extract.Entities:
Year: 2011 PMID: 21702979 PMCID: PMC3132159 DOI: 10.1186/1752-153X-5-34
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Retention times and [M-H]- ions of identified peaks.
| Peak | [M-H]-, | Compound | |
|---|---|---|---|
| 1 | 0.13 | 353 | caffeoylquinic acid |
| 463 | quercetin-3- | ||
| 609 | quercetin-3- | ||
| 2 | 0.16 | 447 | quercetin-3- |
| 3 | 0.34 | 301 | quercetin |
| 4 | 0.96 | 537 | I3, II8-biapigenin |
| 5 | 1.47 | 537 | amentoflavone (I3', II8-biapigenin) |
| 6 | 2.75 | 521 | protopseudohypericin |
| 7 | 2.87 | 519 | pseudohypericin |
| 8 | 3.69 | 505 | protohypericin |
| 9 | 3.83 | 503 | hypericin |
| 10 | 4.80 | 467 | hyperfirin |
| 11 | 4.95 | 481 | adhyperfirin |
| 12 | 5.53 | 535 | hyperforin |
| 13 | 5.68 | 549 | adhyperforin |
Figure 1LC-MS-MS chromatograms (base peak chromatograms, BPC) of : 1. quercetin-3-O-β-D-galactopyranoside (hyperoside) and quercetin-3-O-rutinoside (rutin), 2. quercetin-3-O-α-L-rhamnopyranoside (quercitrin), 3. quercetin, 4. biapigenin, 5. amentoflavone, 6. protopseudohypericin, 7. pseudohypericin, 8. protohypericin, 9. hypericin, 10. hyperfirin, 11. adhyperfirin, 12. hyperforin, 13. adhyperforin
Relative abundancesa of compound classes in analyzed fractions.
| Peaks | Peaks | Peaks | |||||
|---|---|---|---|---|---|---|---|
| Totalb | Phenolic acids | Flavonoid glycosides | Flavonoid aglycones | Biflavonoids | |||
| I-1 | 16.2 | 0.430 | 2.72 | 4.41 | 6.14 | 31.8 | 68.7 |
| I-2 | 37.2 | 1.30 | 6.49 | 20.3 | 3.02 | 49.1 | nd |
| I-3 | 29.9 | nde | 0.414 | 8.49 | 12.7 | 94.1 | 610 |
| I-4 | 0.584 | nd | nd | nd | nd | 137 | 968 |
| I-5 | 420 | nd | nd | 11.7 | 263 | 1000 | nd |
| II-2p | 17.9 | 0.866 | 5.77 | 7.67 | 0.496 | 36.9 | nd |
| II-2s | 17.3 | 0.743 | 5.83 | 6.70 | 1.40 | 41.5 | nd |
| II-3 | 31.4 | 0.257 | 4.50 | 7.75 | 14.2 | 119 | 28.4 |
a given as peak areas divided by injected mass, normalized to 1000 for convenience
b including phenolic acids, flavonoids, biflavonoids and unidentified peaks
c mostly naphthodianthrones
d phloroglucinols
e not detected
Results of antioxidant activity assays.
| DPPH | SO | LP | NO | FRAP | ||
|---|---|---|---|---|---|---|
| Fractions | [μg/umol]a | [mg Fe/g]b | ||||
| I/1 | 1.55 | 69.2 | 11.1 | 2.25 | 32.8 | 80.0 |
| I/2 | 1.09 | 48.7 | 1.86 | 7.92 | > > 22 | 104.0 |
| I/3 | 6.66 | 297 | 11.7 | 17.8 | 53.7 | 10.0 |
| I/4 | 32.8 | 1464 | 20.6 | 2.33 | > 120 | 7.00 |
| I/5 | 11.0 | 491 | 32.4 | 8.09 | 53.7 | 12.0 |
| II/2s | 0.520 | 23.2 | 7.10 | 7.00 | 83.9 | 25.0 |
| II/2p | 1.16 | 51.8 | 5.70 | 12.2 | 30.2 | 44.0 |
| II/3 | 2.61 | 117 | 8.80 | 8.31 | 6.11 | 17.0 |
| BHT | 8.28 | 369 | n/ac | 0.859 | n/a | 25.3 |
| BHA | 12.4 | 553 | n/a | 0.138 | n/a | n/a |
a mass of extract (in μg) needed for 50% neutralization of 1 μmol of DPPH
b mass of Fe3+ that can be reduced by 1 g of H. perforatum fraction.
c 50% inhibition not reached